| Name | Galantamine hydrobromide (JAN/USAN) |
|---|---|
| Synonyms |
(4aS,6R,8aS)-3-Methoxy-11-methyl-5,6,9,10,11,12-hexahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-6-olhydrobromid
MFCD00067672 (4aS,6R,8aS)-3-methoxy-11-methyl-5,6,9,10,11,12-hexahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-6-ol hydrobromide (4aS,6R,8aS)-3-méthoxy-11-méthyl-5,6,9,10,11,12-hexahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazépin-6-ol bromhydrate 5N4SA4KQX9 Galanthamine hydrobromide (1:1) UNII:5N4SA4KQX9 galanthamine bromhydrate (1:1) MJ4PTD2VVW Galantamine hydrobromide (JAN/USAN) Galantamine hydrobromide 6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aS,6R,8aS)-, hydrobromide (1:1) galanthaminhydrobromid(1:1) EINECS 217-780-5 6H-benzofuro[3a,3,2-ef][2]benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aS,6R,8aS)-, hydrobromide |
| Molecular Formula | C17H22BrNO3 |
|---|---|
| Molecular Weight | 368.266 |
| Exact Mass | 367.078308 |
| Symbol |
GHS06 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H301-H315 |
| Precautionary Statements | P301 + P310 |
| RIDADR | UN 2811 6.1 / PGIII |